AzTrials
AzTrials

Cerebral Blood FlowNCT04291326

Cerebral Blood Flow Velocity Changes During Laparoscopic Surgery

An observational study of Cerebral Blood Flow, run by Seoul National University Hospital at 1 site in South Korea.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Little is known about how implementation of pneumoperitoneum contributes to cerebral blood flow in pediatrics. We investigated this question in patients undergoing laparoscopic surgery, hypothesizing that cardiorespiratory changes during this procedure would reduce cerebral perfusion. Read more about this study

Who is it for?
Ages Up to 2 years
Conditions the study is for
Cerebral Blood Flow
What is being tested?
Transfontanelle ultrasound
How many people
30 participants
Where
1 siteSouth Korea
Study dates
20 Mar 2020to 28 Dec 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 2 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: pediatric patients undergoing general anesthesia for laparoscopic surgery

Who may be able to join

  • pediatric patients undergoing laparoscopic surgery

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

South Korea1 site, 1 recruiting
  • Jin-Tae Kim

    Seoul

    Jin-Tae Kim, MD. PhD, 82-2-2072-3664, jintae73@gmail.com

    Recruiting

Other trials in South Korea

About this study

Official title: A Study on Cerebral Blood Flow Velocity Changes During Laparoscopic Surgery in Pediatric Patients: Observational Study Using Transfontanelle Ultrasound

Little is known about how implementation of pneumoperitoneum contributes to cerebral blood flow in pediatrics. We investigated this question in patients undergoing laparoscopic surgery, hypothesizing that cardiorespiratory changes during this procedure would reduce cerebral perfusion.

Being tested
Transfontanelle ultrasound

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transfontanelle ultrasoundDiagnostic test

    cerebral blood flow measurement using transfontanelle ultrasound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cerebral blood flow

    cerebral blood flow measurement using transfontanelle ultrasound

    Measured: intraoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Mar 2020
  2. Study start20 Mar 2020
  3. Primary completion28 Dec 2021 (estimated)
  4. Study completion28 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04291326
Sponsor's protocol ID
2002-036-110
Status last verified
Mar 2021
First submitted
28 Feb 2020
Last updated
16 Mar 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Cerebral Blood Flow, run by Seoul National University Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Mar 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cerebral blood flow (time frame: intraoperative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Mar 2021; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in